Rituximab for the treatment of refractory autoimmune hemolytic anemia in children - Wikidata - wikimedia - TriplyDB

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

http://www.wikidata.org/entity/Q28203568

about

sameAs

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review Treatment of autoimmune hemolytic anemias Rituximab in the treatment of autoimmune haemolytic anaemia Monoclonal antibodies in the treatment of autoimmune cytopenias.Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.Management of Evans syndrome.Treatment with rituximab in benign and malignant hematologic disorders in children.Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.Rituximab in the treatment of autoimmune haematological disorders.Evans syndrome: a study of six cases with review of literature.Stem cell transplantation for patients with Evans syndrome.Effectiveness of cyclosporine and mycophenolate mofetil in a child with refractory evans syndrome.Safety and efficacy of combined cyclophosphamide and rituximab treatment in recalcitrant childhood lupus.Rituximab therapy for refractory autoimmune thrombocytopenia in patients with systemic lupus erythematosus.Rituximab efficacy in the treatment of children with chronic immune thrombocytopenic purpura.How I manage Evans Syndrome and AIHA cases in children.Case report of an acquired factor XIII inhibitor: diagnosis and management.Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases.Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature.B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.B lymphocytes as therapeutic targets in systemic lupus erythematosus.Novel therapies for immune tolerance in haemophilia A.Autoimmune Hemolytic Anemia due to Varicella Infection.Autoimmune hemolytic anemia: classification and therapeutic approaches.Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders.Rituximab in steroid refractory autoimmune hemolytic anemia.Classification and therapeutic approaches in autoimmune hemolytic anemia: an update.Current approaches for the treatment of autoimmune hemolytic anemia.Immunotherapy treatments of warm autoimmune hemolytic anemia.Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Autoimmune Hepatitis with Autoimmune Haemolytic Anemia Triggered by Varicella - a Rare Presentation.Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.Rituximab used in three cases with relapsed non-Hodgkin's lymphoma An Attempt to Induce Transient Immunosuppression Pre-erythrocytapheresis in a Girl With Sickle Cell Disease, a History of Severe Delayed Hemolytic Transfusion Reactions and Need for Hip Prosthesis A fetal hemolytic anemia in a child with cytomegalovirus infection.

P2860

Q24643047-3050998B-10C6-46FF-9309-2FDB420A7759 Q26773178-1687881B-C172-486E-8692-7AB9FF2F3E06 Q26866954-F8830AD1-A68D-48AE-9F7B-F2445C7539BC Q27023114-8E18403C-D323-4019-9314-2A6210607BA7 Q33359539-59903FE7-8997-4370-8D79-13B002BA4B53 Q33359900-F55902A0-A81C-419E-BBF3-92ECD26F8292 Q33360255-CDA98059-F40E-4523-9331-51EC88CBF60F Q33369826-87389759-6770-455C-A30A-19B54F4D8875 Q33374660-35418054-F36F-4F70-A127-8FBDF444192F Q33375244-D614B17C-BFE2-4CFF-B16C-C31433330C92 Q33378854-DAEEAA3D-8526-4DCE-B654-97FC04B1B747 Q33382284-2FF5F801-EB72-438D-95B6-FA5928D981F1 Q33389601-05FF9407-EA3C-451A-8495-ADF455583B1E Q33396299-6779F6AE-3161-4440-BEF1-35612BA1113B Q33411406-2E28BAD6-4157-4927-806F-8F4047261DF6 Q33414696-68A8702D-D2FE-4C1B-9CCE-EA7DAF4D0BDF Q33416359-56AEB2C8-32F4-4F2E-8521-927E812A0E0E Q33428041-9C84DA3C-F928-4C1E-8BF7-9CD670714914 Q34703713-E9895BD3-DBF8-42B9-8B6C-72599E7B9BCB Q35064588-4F9F1714-55A2-47BA-8A2D-A8CF50A10337 Q35237511-499CC99D-6950-41A9-BD2B-61DBA3E876E3 Q36088058-98D43A01-C218-432D-9382-E59885B4D607 Q36462009-75AA5401-01E3-4149-A69A-731BDE97A0F3 Q36577391-0C6A74C2-E625-4A78-9D1D-87733B0B9285 Q36653646-95F7AFDD-8B64-4879-A30C-1FDD69265C56 Q36661858-DEE7FE47-C05D-4143-8497-144C12107DD0 Q37443881-7B09A567-6E16-4495-B66D-90F85F3DCE7A Q37810065-67AB7609-564A-4841-B2FE-FB0FEA3D851B Q37843939-C28F3ADE-7197-4235-9062-F48BDBFBF506 Q37914758-4A45B311-EB08-431C-919A-CB6F61BCA01C Q37955228-CD5D754D-0CAE-41AE-A11F-3F5304E9B08C Q38108152-CFE161B1-D93A-4239-A9A3-68BE8FA2FEAA Q38150845-95A6F834-4EF8-4A34-A75E-4B12CF834C57 Q38819009-343D46BC-D55E-4868-AE10-26F3C655DB87 Q39264020-3A587A4F-57E9-4DDE-BFBD-3F0979E7034E Q40042425-1F44527C-A7E1-438D-8F4D-294CD6CAF322 Q41172796-438E5AC3-DA15-4D0D-B4F9-5C4336A2DB71 Q41920305-49C65914-287C-4F1C-84EE-10ABBDE3199A Q41982475-E3A16945-8BCE-47DF-A815-EF57F3E37915 Q42111292-624E4B4B-7C27-404D-9743-C696F387999F

P2860

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

http://www.wikidata.org/entity/Q28203568

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@ast

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@en

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@nl

type

label

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@ast

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@en

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@nl

prefLabel

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@ast

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@en

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@nl

P1433

Q28203568-2F784E37-3FE9-4317-BF4D-7675FD194FDB

P1476

Q28203568-E6175DFB-AE8D-4517-AF54-77F3A7D31FB4

P2093

Q28203568-088092EB-1547-47F1-88E7-783FA5EE9D22

Q28203568-130CEEDB-A5DB-4D0A-B45E-A85A918865A9

Q28203568-442B5ABC-C526-4653-BBD4-597F16D95D51

Q28203568-4F121CD4-4D0D-4705-BA8A-AEAB78F36602

Q28203568-678780C7-E3C9-462F-AF93-7F44B234D91C

Q28203568-7FBDDFDF-4CA7-4DFF-B436-9EBA5EDE885A

Q28203568-80BFD113-D337-443E-AFD7-6D3A072AAD64

Q28203568-B1AAFF8D-98D3-47A8-BABB-7B470A2B2E84

Q28203568-B3F3C3E2-7A90-4C88-8C59-B92E54175E46

Q28203568-E89DC3C4-F151-48EE-9461-FEF7F083AE72

P304

Q28203568-EC7FB382-A0FA-4F67-89BF-637A330D8EB1

P31

Q28203568-3FE13EBC-5D27-431B-8D9E-0A72186DF050

P356

Q28203568-3895DC5B-09B3-40DB-8EDF-297E37E8EF8F

P407

Q28203568-DAA72086-B5E3-4E89-BAB8-9BEA988A9BCF

P433

Q28203568-950F6BEF-D98C-41E2-A3F4-D592E17E87D3

P478

Q28203568-4E6A61E5-6686-41B5-A20D-7B95FA545340

P50

Q28203568-5DA20475-A5EE-4456-8358-FDCC88DA2F7A

P577

Q28203568-243A3B72-7148-4721-904B-9C76F638F8FA

P5875

Q28203568-A9DA7ECC-D116-4D01-9D5C-9A1A85E8C7FA

P698

Q28203568-291D2DDF-88D0-4D0C-BB79-456AE0B421C2

P356

BLOOD-2002-11-3547

P1433

P1476

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

@en

P2093

Bruno Nobili

http://www.w3.org/2001/XMLSchema#string

Giovanni Amendola

http://www.w3.org/2001/XMLSchema#string

Marco Zecca

http://www.w3.org/2001/XMLSchema#string

Mario Regazzi Bonora

http://www.w3.org/2001/XMLSchema#string

Momcilo Jankovic

http://www.w3.org/2001/XMLSchema#string

Paolo Pierani

http://www.w3.org/2001/XMLSchema#string

Pasquale Rosito

http://www.w3.org/2001/XMLSchema#string

Piero De Stefano

http://www.w3.org/2001/XMLSchema#string

Silverio Perrotta

http://www.w3.org/2001/XMLSchema#string

Ugo Ramenghi

http://www.w3.org/2001/XMLSchema#string

P304

3857-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2002-11-3547

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Franco Locatelli

P577

2003-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5333208

http://www.w3.org/2001/XMLSchema#string

P698

12531800

http://www.w3.org/2001/XMLSchema#string